2011
DOI: 10.1126/science.1204839
|View full text |Cite
|
Sign up to set email alerts
|

A Highly Conserved Neutralizing Epitope on Group 2 Influenza A Viruses

Abstract: Current flu vaccines provide only limited coverage against seasonal strains of influenza viruses. The identification of VH1-69 antibodies that broadly neutralize almost all influenza A group 1 viruses constituted a breakthrough in the influenza field. Here we report the isolation and characterization of a human monoclonal antibody CR8020 with broad neutralizing activity against most group 2 viruses, including H3N2 and H7N7, which cause severe human infection. The crystal structure of Fab CR8020 with the 1968 p… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

14
833
3
7

Year Published

2012
2012
2016
2016

Publication Types

Select...
5
4

Relationship

1
8

Authors

Journals

citations
Cited by 782 publications
(859 citation statements)
references
References 39 publications
14
833
3
7
Order By: Relevance
“…Viruses undergoing high gene variation will typically silence their broad neutralizing sites when infiltrating the immune system of the host, as exemplified by HIV [22] and Influenza virus [23][24][25]. We next sought to determine the predominance of 8G12-like antibodies in the anti-HEV pools during the immune responses elicited by HEV infection and vaccine inoculation.…”
Section: Mab 8g12 Blocks the Binding Of Naturally Acquired Antibodiesmentioning
confidence: 99%
“…Viruses undergoing high gene variation will typically silence their broad neutralizing sites when infiltrating the immune system of the host, as exemplified by HIV [22] and Influenza virus [23][24][25]. We next sought to determine the predominance of 8G12-like antibodies in the anti-HEV pools during the immune responses elicited by HEV infection and vaccine inoculation.…”
Section: Mab 8g12 Blocks the Binding Of Naturally Acquired Antibodiesmentioning
confidence: 99%
“…Antibodies directed against the globular domain of HA, as well as the highly conserved stem region, efficiently neutralize the virus. The identification of broadly neutralizing antibodies that target highly conserved stem epitopes offers the exciting prospect of designing universal or pan-influenza vaccines that can protect against IAV expressing several or all subtypes of HA (10,(15)(16)(17)(18)(19)(20).…”
mentioning
confidence: 99%
“…Différentes équipes de recherche, dont la nôtre, ont récemment décrit des anticorps monoclonaux humains capables de neutraliser différents sous-types du groupe 1 et/ou du groupe 2 des virus influenza A (Figure 1) [2,[4][5][6]8]. Jusqu'à aujourd'hui, moins d'attention avait été portée aux virus influenza B, probablement parce qu'ils n'infectent pas les oiseaux aquatiques, réservoir clé pour l'émergence des pandémies.…”
Section: Anticorps Neutralisant Le Virus Grippalunclassified
“…Les virus influenza B ne ségrègent pas en sous-types, mais leur évolution est caractérisée par la cocirculation de deux lignées possé-dant des caractéristiques génétiques et antigéniques différentes ( Figure 1B) [7]. L'HA, une glycoprotéine antigé-nique présente à la surface du virus de la grippe, est nécessaire à l'atta-A (bnAb, broadly neutralizing antibodies) [2][3][4][5][6] [2,4,6]. Cette région hautement conservée se situe au niveau de la partie de l'HA proche de la membrane appelée stem 1 (Figure 3).…”
Section: L'hémagglutinine : Cible Des Anticorps Neutralisantsunclassified